Basic Information
Basic information for SNHG11-229-21aa
Peptide Name SNHG11-229-21aa
Genome Position chr20:38447371-38447433[+]
Species Human
Peptide Sequence MEDAPRAPEGRIPDSFARTLY
Peptide Length 21
Unique No (SNHG11-202-21aa,SNHG11-203-21aa,SNHG11-214-21aa,SNHG11-215-21aa,SNHG11-221-21aa,SNHG11-225-21aa,SNHG11-226-21aa,SNHG11-227-21aa,SNHG11-232-21aa,SNHG11-235-21aa,SNHG11-236-21aa,SNHG11-237-21aa)
Grand Average of Hydropathicity -0.8143
Relative Molecular Mass 2752.97
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000174365;SNHG11
Transcript ID/Name ENST00000663763;SNHG11-229
Transcript Length 4108
Coding Ability 0.4056
DNA Sequence Corresponding to Peptide ATGGAGGACGCTCCCAGGGCCCCAGAGGGGCGAATTCCAGACTCCTTTGCCAGGACCTTGTAC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :